Dyslipidemic effects cigarette smoking beta-blocker-induced serum lipid changes systemic hypertension effects beta blockers lipids apolipoproteins cigarette smokers nonsmokers patients systemic hypertension month placebo months beta-blocker monotherapy Serum total cholesterol triglycerides high-density lipoprotein HDL cholesterol low-density lipoprotein LDL cholesterol Total cholesterol propranolol smokers nonsmokers vs smokers nonsmokers atenolol pindolol groups celiprolol vs HDL cholesterol propranolol smokers nonsmokers vs smokers nonsmokers pindolol groups celiprolol Similar trends LDL cholesterol total/HDL cholesterol ratio noncardioselective beta blockers propranolol significant dyslipidemic effects smokers nonsmokers Cardioselective drugs atenolol metoprolol drugs partial agonist activity pindolol variable effects Celiprolol new cardioselective beta blocker partial beta agonist activity vasodilatory properties favorable effects lipids dyslipidemic effects smoking 